Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |